Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Belotecan

Generic Name: Belotecan

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₇N_₃O_₄

CAS Number: 256411-32-2

Unique Ingredient Identifier: 27Z82M2G1N

Overview

Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.

Background

Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer

Phase 1

Posted: 2013/02/05

Sponsor:Gachon University Gi...

ID:NCT01784107

Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

Phase 2

Completed

Posted: 2012/06/28

Sponsor:Chong Kun Dang Pharm...

ID:NCT01630018

A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

Phase 2

Completed

Posted: 2011/12/23

Sponsor:Chong Kun Dang Pharm...

ID:NCT01497873

Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy

Phase 2

Completed

Posted: 2009/12/01

Sponsor:Chong Kun Dang Pharm...

ID:NCT01022671

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Phase 3

Completed

Posted: 2009/01/22

Sponsor:Chonnam National Uni...

ID:NCT00826644

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy